ZOM

Zomed Pharm
AMEX

Real-time Quotes | Nasdaq Last Sale

0.1681
-0.0029
-1.70%
After Hours: 0.1685 +0.0004 +0.24% 19:59 07/10 EDT
OPEN
0.1710
PREV CLOSE
0.1710
HIGH
0.1710
LOW
0.1660
VOLUME
44.01M
TURNOVER
--
52 WEEK HIGH
0.4990
52 WEEK LOW
0.1100
MARKET CAP
60.69M
P/E (TTM)
-1.7547
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ZOM stock price target is 0.5000 with a high estimate of 0.5000 and a low estimate of 0.5000.

EPS

ZOM News

More
Zomedica Pharmaceuticals Corp. Closes $30 Million Public Offering
GlobeNewswire · 3d ago
66 Biggest Movers From Thursday
Gainers GEE Group, Inc. (NYSE: JOB) shares climbed 199.9% to close at $1.54 on Thursday after the company eliminated over $47 million in debt and mezzanine financing.
Benzinga · 4d ago
NUS, CPST, SOLO and MEIP among midday movers
Seeking Alpha - Article · 07/02 16:42
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1)
Benzinga · 07/02 12:21
Zomedica Pharmaceuticals Prices 187.5M Share/Warrant Public Offering @$0.16/Share & Warrant
Zomedica Pharmaceuticals Corp.
Benzinga · 07/02 09:39
Zomedica Pharma prices equity offering at $0.16
Seeking Alpha - Article · 07/02 06:45
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering
GlobeNewswire · 07/01 21:04
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering; No Terms Disclosed
Benzinga · 07/01 20:04

Industry

Biotechnology & Medical Research
-0.39%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Symbol
Price
%Change

About ZOM

Zomedica Pharmaceuticals Corp is a development stage veterinary diagnostic and pharmaceutical company. The Company is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. It is focused on developing three diagnostic platforms, a Bulk Acoustic Wave sensor-based veterinary point-of-care diagnostic platform for performing immunodiagnostic testing, a Raman spectroscopy-based point-of-care diagnostic platform for the detection of pathogens, and liquid biopsy assays for the detection of cancer, along with related consumables. The Company’s TRUFORMA product candidate is an investigational device being developed as a point-of-care biosensor platform. ZM-020 is its diagnostic platform being developed to screen for a range of pathogens in companion animal feces, urine, respiratory, and dermatological samples. It is developing ZM-017 as a canine cancer liquid biopsy platform.
More

Webull offers kinds of Zomedica Pharmaceuticals Corp stock information, including AMEX:ZOM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZOM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ZOM stock methods without spending real money on the virtual paper trading platform.